CRH Medical Corp (CRHM) Short Interest Down 3.7% in December

CRH Medical Corp (NYSEAMERICAN:CRHM) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 1,427,572 shares, a decrease of 3.7% from the November 30th total of 1,483,184 shares. Based on an average daily volume of 214,895 shares, the short-interest ratio is presently 6.6 days. Currently, 2.0% of the company’s stock are short sold.

Several hedge funds and other institutional investors have recently bought and sold shares of CRHM. Vanguard Group Inc. purchased a new position in shares of CRH Medical in the 2nd quarter valued at $150,000. Bank of Montreal Can boosted its stake in CRH Medical by 128.4% during the 2nd quarter. Bank of Montreal Can now owns 28,700 shares of the company’s stock worth $164,000 after purchasing an additional 16,135 shares during the period. Advisor Group Inc. boosted its stake in CRH Medical by 35.0% during the 2nd quarter. Advisor Group Inc. now owns 36,177 shares of the company’s stock worth $206,000 after purchasing an additional 9,389 shares during the period. PDT Partners LLC boosted its stake in CRH Medical by 176.4% during the 2nd quarter. PDT Partners LLC now owns 50,162 shares of the company’s stock worth $285,000 after purchasing an additional 32,013 shares during the period. Finally, TD Asset Management Inc. boosted its stake in CRH Medical by 65.3% during the 3rd quarter. TD Asset Management Inc. now owns 111,054 shares of the company’s stock worth $289,000 after purchasing an additional 43,851 shares during the period.

CRH Medical (NYSEAMERICAN:CRHM) opened at $2.50 on Thursday. The company has a market cap of $196.44, a price-to-earnings ratio of 35.71 and a beta of 1.32. CRH Medical has a 52-week low of $1.46 and a 52-week high of $9.25.

A number of brokerages have commented on CRHM. Zacks Investment Research raised shares of CRH Medical from a “sell” rating to a “hold” rating in a research report on Monday, November 27th. Morgan Stanley raised shares of CRH Medical from an “equal weight” rating to an “overweight” rating in a research report on Friday, November 17th. Four research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $7.50.

TRADEMARK VIOLATION WARNING: “CRH Medical Corp (CRHM) Short Interest Down 3.7% in December” was first reported by Week Herald and is the property of of Week Herald. If you are accessing this piece on another website, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The original version of this piece can be accessed at https://weekherald.com/2017/12/28/crh-medical-corp-crhm-short-interest-down-3-7-in-december.html.

About CRH Medical

CRH Medical Corporation is a Canada-based healthcare products and services company. The Company focused on providing physicians with services and products for the treatment of gastrointestinal diseases. The Company also provides anesthesiology services to gastroenterologists in the United States through its subsidiaries.

Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply